Maxalt
Product Images NDC 21695-956
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Maxalt (NDC 21695-956). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image Of Figure 1 (3f30e6a5 F3c0 4c20 B1a2 142575eb0e24 02)
Image Of Figure 2 (3f30e6a5 F3c0 4c20 B1a2 142575eb0e24 03)
Image Of Figure 3 (3f30e6a5 F3c0 4c20 B1a2 142575eb0e24 04)
The text contains a description of a Kaplan-Meier plot of the probability of obtaining headache response after treatment with MAXALT-MLT or placebo based on data from two placebo-controlled trials. The plot shows the average probabilities over time, and patients who did not achieve response within 2 hours or took additional treatment were censored at 2 hours.*
Image Of Figure 4 (3f30e6a5 F3c0 4c20 B1a2 142575eb0e24 05)
Maxalt 10mg (3f30e6a5 F3c0 4c20 B1a2 142575eb0e24 06)
Maxalt 10mg is a medication that comes in the form of tablets. Each tablet contains 10mg of Rizatriptan Benzoate, which is equivalent to 8mg of Rizatriptan. The package contains 18 tablets. The product is identified by the Product ID: RM095618. This medication is manufactured by MSD, Ltd. in Cramlington, Northumberland, NE23 3JU, UK.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.